Search Ontology:
ChEBI
mirodenafil
- Term ID
- CHEBI:136049
- Synonyms
-
- 5-ethyl-2-(5-{[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl}-2-propoxyphenyl)-7-propyl-3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one
- mirodenafil
- mirodenafilo
- mirodenafilum
- SK-3530
- SK3530
- Definition
- A member of the class of pyrrolopyrimidines that is 3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one having a 5-{[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl}-2-propoxyphenyl group at positon 2, ethyl group at position 5, and a propyl group at position 7. It is a phosphodiesterase type 5 inhibitor which is used for the treatment of erectile dysfunction.
- References
-
- cas:862189-95-5
- chemspider:10173481
- drugbank:DB11792
- drugcentral:5005
- patent:KR20080062434
- pubmed:18098061
- pubmed:19057138
- pubmed:19095395
- pubmed:19639551
- pubmed:19929308
- pubmed:20456834
- pubmed:20649936
- pubmed:20861845
- pubmed:21162118
- pubmed:21478894
- pubmed:22692776
- pubmed:22921287
- pubmed:23006442
- pubmed:23017527
- pubmed:23303333
- pubmed:23390072
- pubmed:23700501
- pubmed:23937271
- pubmed:24219508
- pubmed:24872948
- pubmed:25162329
- pubmed:25606563
- pubmed:25833477
- pubmed:26919966
- pubmed:27034723
- pubmed:32388784
- pubmed:32981502
- wikipedia.en:Mirodenafil
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from mirodenafil
Phenotype where environments contain mirodenafil
Phenotype modified by environments containing mirodenafil
Phenotype affecting mirodenafil
Human Disease Model